<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Expression Profile of Neuro-Endocrine-Immune Network in Rats with Vascular Endothelial Dysfunction</title>
			</titleStmt>
			<publicationStmt>
				<publisher>The Korean Physiological Society and The Korean Society of Pharmacology (KAMJE)</publisher>
				<availability status="unknown"><p>Copyright The Korean Physiological Society and The Korean Society of Pharmacology (KAMJE)</p>
				</availability>
				<date type="published" when="2014">2014</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lujin</forename><surname>Li</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">The Center for Drug Clinical Research</orgName>
								<orgName type="institution">Shanghai University of Chinese Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhenghua</forename><surname>Jia</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">The Integration of Traditional and Western Medical Research Academy of Hebei Province</orgName>
								<address>
									<settlement>Shijiazhuang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ling</forename><surname>Xu</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">The Center for Drug Clinical Research</orgName>
								<orgName type="institution">Shanghai University of Chinese Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yiling</forename><surname>Wu</surname></persName>
							<email>yilingwu5109@163.com</email>
							<affiliation key="aff3">
								<orgName type="department">The Integration of Traditional and Western Medical Research Academy of Hebei Province</orgName>
								<address>
									<settlement>Shijiazhuang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Qingshan</forename><surname>Zheng</surname></persName>
							<email>qingshan.zheng@drugchina.net</email>
							<affiliation key="aff2">
								<orgName type="department">The Center for Drug Clinical Research</orgName>
								<orgName type="institution">Shanghai University of Chinese Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">Shanghai University of Chinese Medicine</orgName>
								<address>
									<addrLine>1200 Cailun Road</addrLine>
									<postCode>201203</postCode>
									<settlement>Shanghai</settlement>
									<region>No</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">The Integration of Traditional and Wes-tern Medical Research Academy of Hebei Province</orgName>
								<address>
									<addrLine>Yiling Wu</addrLine>
									<postCode>050035</postCode>
									<settlement>Shijiazhuang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Expression Profile of Neuro-Endocrine-Immune Network in Rats with Vascular Endothelial Dysfunction</title>
					</analytic>
					<monogr>
						<title level="j" type="main">The Korean Journal of Physiology &amp; Pharmacology</title>
						<title level="j" type="abbrev">Korean J Physiol Pharmacol</title>
						<idno type="ISSN">1226-4512</idno>
						<idno type="eISSN">2093-3827</idno>
						<imprint>
							<publisher>The Korean Physiological Society and The Korean Society of Pharmacology (KAMJE)</publisher>
							<biblScope unit="volume">18</biblScope>
							<biblScope unit="issue">2</biblScope>
							<biblScope unit="page">177</biblScope>
							<date type="published" when="2014" />
						</imprint>
					</monogr>
					<idno type="DOI">10.4196/kjpp.2014.18.2.177</idno>
					<idno type="PMID">24757381</idno>
					<idno type="PMCID">PMC3994306</idno>
					<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0067KJPP/kjpp-18-177.pdf" />
					<note type="submission">Received January 27, 2014, Revised February 13, 2014, Accepted February 26, 2014</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-14T00:56+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>5-HT, 5-hydroxytryptamine</term>
					<term>ACTH, adrenocorticotropic hormone</term>
					<term>ALD, aldosterone</term>
					<term>AngII, angiotensin II</term>
					<term>CORT, corticosterone</term>
					<term>CRH, corticotropin-releasing hormone</term>
					<term>DA, dopamine</term>
					<term>E, epinephrine</term>
					<term>ET, endothelin</term>
					<term>Hcy, homocysteine</term>
					<term>HFD, high fat diet</term>
					<term>HPAA, hypothalamus-hypophysis-adrenal cortex axis</term>
					<term>HPLC, high-performance liquid chromatography</term>
					<term>HPTA, hypothalamushypophysis-thyroid gland axis</term>
					<term>IFN-γ, interferon-γ</term>
					<term>IL, immune factors</term>
					<term>LDL-c, low density lipoprotein cholesterol</term>
					<term>NE, norepinephrine</term>
					<term>NEI, neuro-endocrine-immune</term>
					<term>NO, nitric oxide</term>
					<term>PCA, principal component analysis</term>
					<term>PRA, plasma renin activity</term>
					<term>RAAS, renin-angiotensin-aldosterone system</term>
					<term>SAM, sympathesis-adrenalmedulla axis</term>
					<term>sICAM-1, soluble intercellular adhesion molecule-1</term>
					<term>Sim, simvastatin</term>
					<term>T3 or T4, thyroid hormone</term>
					<term>TC, total cholesterol</term>
					<term>TG, triglyceride</term>
					<term>TNF-α, tumor necrosis factor-α</term>
					<term>TRH, thyrotropinreleasing hormone</term>
					<term>TSH, thyrotropic-stimulating hormone</term>
					<term>vWF, von Willebrand factor Endocrine system, Immune system, Nervous system, Vascular endothelial dysfunction</term>
				</keywords>
			</textClass>
			<abstract>
				<p>This study was to determine the correlation between endothelial function and neuro-endocrineimmune (NEI) network through observing the changes of NEI network under the different endothelial dysfunction models. Three endothelial dysfunction models were established in male W istar rats after exposure to homocysteine (Hcy), high fat diet (HFD) and Hcy+HFD. The results showed that there was endothelial dysfunction in all three models with varying degrees. However, the expression of NEI network was totally different. Interestingly, treatment with simvastatin was able to improve vascular endothelial function and restored the imbalance of the NEI network, observed in the Hcy+HFD group. The results indicated that NEI network may have a strong association with endothelial function, and this relationship can be used to distinguish different risk factors and evaluate drug effects.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>The neuro-endocrine-immune (NEI) network, first proposed by Besedovsky in 1977 <ref type="bibr" target="#b0">[1]</ref>, plays a pivotal role in regulating homeostasis and optimizing health and makes great contributions to various complex diseases. Endothelial dysfunction of either the coronary-, the peripheral-or the cerebral vasculature is a predictor of vascular events and appears to be a marker of atherosclerotic risk. As the largest endocrine organ of the body, the endodermis can receive signals of neurotransmitters, hormones and cytokines <ref type="bibr" target="#b1">[2]</ref>, and can this way be controlled by the NEI network. This fact suggested that NEI network may be a potentially ideal index for the evaluation of endothelial dysfunction.</p><p>A variety of cardiovascular risk factors have been shown to induce vascular endothelial dysfunction, including smoking <ref type="bibr" target="#b2">[3]</ref>, hyperlipidemia <ref type="bibr" target="#b3">[4]</ref>, hypertension <ref type="bibr" target="#b4">[5]</ref>, hypoxia <ref type="bibr" target="#b5">[6]</ref> and high levels of homocysteine (Hcy). Hyperlipidemia and hyperhomocysteinemia are closely associated with diet, and are currently occurring more often with the popularity of fast food. This problem has been attained global scale. Therefore, in this study high fat diet (HFD) and high methionine diet were used to induce endothelial dysfunction model in rats.</p><p>Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary artery disease. It was found that statins appear to have a pleiotropic effect beyond their lipid-lowering ability. They can also exert anti-inflammatory, anti-thrombotic and anti-oxidant effects, increase NO production and improve endothelial function <ref type="bibr" target="#b6">[7]</ref>. Here, an interesting question is proposed that whether statins can also improve the expression of NEI network.</p><p>The objective of the present study was to determine the correlation between endothelial function and NEI network under different endothelial dysfunction models caused by HFD, Hcy and Hcy+HFD. The effect of simvastatin (Sim) on NEI network profile was also evaluated in the models of endothelial dysfunction. </p><formula xml:id="formula_0">L Li, et al TC (mmol/L) TG (mmol/L) LDL-C (mmol/L)</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animals and experimental groups</head><p>The experiment was approved by the Institutional Animal Care and Use Committee of Shanghai University of Chinese Medicine. Fifty male Wistar rats (Shanghai Lab. Animal Research Center, China) weighing 200∼250 g were randomly divided into five groups fed on either ordinary diet (control group), high fat diet (HFD group; every 100 g ordinary diet was supplemented with 15 g of palm oil, 5 g of dried whole milk, 3 g of cholesterol and 0.5 g of sodium cholate), high Hcy diet (Hcy group; ordinary diet containing 3% methionine), high Hcy and high fat diet (Hcy+ HFD group), or high Hcy and high fat diet combined with simvastatin (Hcy+HFD+Sim group; simvastatin was administered via gavage with a dose of 5 mg/kg per day, simvastatin was provided by Hangzhou MSD Pharmaceutical Co. Ltd). The animals were housed in an environmentally controlled room (temperature 20∼25 o C; humidity 45%∼ 65%) for 12 weeks. Throughout the study, the animals were allowed free access to food and tap water.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample preparation and measurement</head><p>To evaluate endothelial function, some indices such as endothelin (ET), nitric monoxide (NO), von Willebrand factor (vWF) <ref type="bibr" target="#b7">[8]</ref> and soluble intercellular adhesion molecule-1 (sICAM-1) <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref> were determined. In addition, nineteen indices were measured to reflect the profile of NEI network, they are: At the end of the experiment, blood samples were collected from the carotid artery after the rats were anesthetized (30 mg/kg butaylone intraperitoneally). Each blood sample was divided into three aliquots. The first aliquot (1 ml) was mixed with 30μL of 10% EDTA and 40μL of aprotinin. Samples were centrifuged at 3000 rpm for 5 min at 4 o C.</p><p>Radio-immunoassays were performed to measure the levels of ET, CRH, ALD and ACTH (test kits were provided by Purevalley Biotech, China). The second aliquot of serum (0.5 ml) put into an anticoagulant tube with 10% EDTA-Na2 and enzyme inhibitor, and was kept on ice. After mixing the serum was centrifuged at 3000 rpm for 5 min. at 4 o C. Radio-immunoassays were used to measure the levels AngII of and PRA (test kits were provided by Beijin North Institute of Biological Technology, China), the total Hcy were determined using high-performance liquid chromatography (HPLC) <ref type="bibr" target="#b10">[11]</ref>. A third aliquot of serum (3 ml) was used for ELISA detection of vWF, sICAM-1, NE, E and TRH. The levels of TSH, T3, T4, CORT, IL-1β, IL-2, IL-6, IFN-γ and TNF-α were measured by radio-immunoassays (test kits were provided by Beijin North Institute of Biological Technology). Serum NO concentration was measured by the method of nitric acid reductase (test kits were provided by Nanjing Jiancheng Bioengineering Institute, China). The serum concentrations of triglyceride (TG), the total cholesterol (TC) and the low density lipoprotein cholesterol (LDL-C) were measured using an auto-biochemical analyzer (OLYMPUS AU-600).</p><p>After the blood sampling, the hypothalamus was resected immediately and the obtained tissue was snap-frozen in dry ice (-70 o C) and stored until use for biochemical assessments. DA and 5-HT were assayed by electrochemical detection using HPLC <ref type="bibr" target="#b11">[12]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data Processing</head><p>SAS v9.1.3 software was used for data analysis. Results were presented as means±SD. The significance of differences between groups were analyzed by the Dunnett's t-test and the student's t-test. Statistical significance was set at p＜0.05.</p><p>The bootstrapping method was repeated 1000 times to estimate the 95% confidence interval of the ratio of each NEI index between the groups. If 95% confidence interval of the ratio is lower or higher than 1, this indicates that the expression of the index in the test group is significantly lower or higher than that in the control group.</p><p>The NEI network data with 19 indices can be simplified by principal component analysis (PCA) <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>, which can transform a large number of indices into only two or three latent variables known as principal components. Thus, the high dimension information can be visualized as a scatter plot, in which each data point represents one rat sample, and the distance between points in the score plot is an indication of the similarity between samples. In addition, loading plots from PCA were used to rank the importance of each variable to further capture the differentially expressed indices accountable for the separation between  groups.</p><formula xml:id="formula_1">179 ET (ng/L) NO (μmol/L) vWF (%) sICAM-1 (</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The levels of lipids and Hcy in each group</head><p>As shown in <ref type="table">Table 1</ref>, the levels of TC, TG and LDL-C in the HFD and Hcy+HFD groups were significantly increased as compared with the control group. In addition, the Hcy level was significantly increased in the Hcy and the Hcy+HFD groups compared to those of the control group. These results indicated that the models were successfully established.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Vascular endothelial function</head><p>As shown in <ref type="table" target="#tab_2">Table 2</ref>, vascular endothelial function was found to be impaired at different levels in the Hcy-, HFDand Hcy+HFD groups. Hcy+HFD induced endothelial dysfunction was most serious. However, ET level was not significantly changed following HFD when compared with normal rats. In addition, simvastatin showed a protective effect on endothelial function. <ref type="figure">Fig. 2</ref>. PCA scores (A) and loading plots (B) derived from the scores of separate principle component analyses of the Hcy-, HFD-and Hcy+HFD groups. PCA score plots illustrate that the Hcy-, HFDand Hcy+HFD groups are well separated from the control, suggesting that the NEI network has been affected due to the different treatments. The major markers responsible for class separation are revealed by the PCA loading plots, which represent the importance to the inter-group differences within the discrimination model. The established PCA model was then used to predict the scores of PCs in the Hcy+HFD+Sim group (C), providing a visual picture of the recovery of the NEI network after treatment with simvasatin. The heat map (D) shows the changes in the NEI network of control group, compared with the Hcy-, HFD-and Hcy+HFD groups, or the Hcy+HFD+Sim group compared with Hcy+HFD group. Shades of red and blue represent fold increase and decrease of the different indices in the indicated groups.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NEI network profile</head><p>A number of marked changes in the NEI network were observed in rats following the different treatments. The bootstrapping method was used to estimate the 95% confidence interval of the ratio of the test group, relative to the control group <ref type="figure">(Fig. 1)</ref>. In order to make the results better interpretable, principle component analyses (PCA) were employed for processing these complex data.</p><p>The PCA score plots showed an almost complete separation among the control and model groups ( <ref type="figure">Fig. 2A)</ref>, principal components 1 (PC1) and 2 (PC2) explained 26.38% and 14.63% of the total variance. The PCA loading plots <ref type="figure">(Fig.  2B</ref>) indicated the contribution of the 19 indices to the differences observed among the samples. Hcy+HFD treated animals were well separated from the normal animals along the first PC, and this mainly arose from the variation of T4, PRA, AngII, TNF-α, IFN-γ and CORT data. The results indicated that the PC1 mainly reflected the information of the RAAS and immune system. HFD treaded animals were separated from Hcy treated animals along the PC2, and this arose from the main variation of 5-HT, ACTH and E data. These key indices selected from PCA model showed significant differences between the control and the experimental groups <ref type="figure" target="#fig_1">(Fig. 3)</ref>. The PCA model calculated from the data of the control and model groups was then used to predict the scores of PCs in the Hcy+HFD+Sim group. As shown in <ref type="figure">Figure 2B</ref>, the expression of NEI network in the Hcy+HFD+Sim group obviously deviated from that in the Hcy+HFD group, and approached the state of the control group. The results suggested that simvastatin has an obvious regulatory effect on the NEI network.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>Endothelial dysfunction is thought to be a key event in the development of atherosclerosis and has been reported to predate clinically obvious vascular pathology by many years. Previous literatures have demonstrated that exposure to homocysteine (Hcy) and high fat diet (HFD) can lead to vascular endothelial dysfunction, but the main differences between Hcy and HFD is still unclear. In this study, we compared two models of exposure to Hcy and HFD respectively, with the combined model of Hcy+HFD on vascular endothelial function. The results showed that the vascular endothelial function was affected in all three model groups, in which the No level was significantly decreased and the vWF and sICAM-1 levels were significantly increased. However, there were still some differences among the model groups. For example, the ET level was not obviously changed in the HFD group, and endothelial function was impacted most seriously in the Hcy+HFD group. In addition, endothelial function of the rats in the Hcy+HFD+ Sim group showed a recovery tendency because the levels of ET, vWF and sICAM-1 were significantly lower and NO was significantly higher than in the Hcy+HFD group.</p><p>The interdisciplinary fields of neuroendocrine and immune systems have undergone explosive growth in recent years <ref type="bibr" target="#b14">[15]</ref>. Increasing evidence has shown that the NEI network plays a pivotal role in regulating homeostasis and optimizing health and makes great contributions to various complex diseases <ref type="bibr" target="#b15">[16]</ref>. In this study, we also observed the changes of the NEI network in the three models. The results suggested that Hcy mainly affected the balance of neurotransmitters, HPTA and SAM, while HFD mainly influenced the HPAA, HPTA and RAAS. The combination of Hcy and HFD impacted almost the whole NEI network and showed synergetic damaging effects. It is worth mentioning that, simvastatin reversed the imbalance of the NEI network disturbed by the Hcy+HFD, especially visible at the levels of DA, CRH, CORT, T4, PRA, ALD, IL-6 and TNF-α, suggesting that the regulatory role of simvastatin on endothelial function may be associated with the NEI network.</p><p>A growing number of reports have demonstrated the close relationship between endothelial function and NEI net- work: (1) Endothelial function in patients with severe chronic heart failure can be improved by DA <ref type="bibr" target="#b16">[17]</ref>, suggesting that neurotransmitters may play a key role in the pathogenesis of endothelial dysfunction; (2) AngII can lead to endothelial dysfunction via AngII receptor subtypek 1 activation and reactive oxygen-and nitrogen species generation <ref type="bibr" target="#b17">[18]</ref>; (3) L-thyroxine therapy can improve endothelial function in the subclinical hypothyroidism patients <ref type="bibr" target="#b18">[19]</ref>; (4) CRH can induce a significant increase of ET-1 release <ref type="bibr" target="#b19">[20]</ref>; (5) Endothelial dysfunction occurring in the metabolic syndrome is the result of effects of the inflammatory cytokine TNF-α and subsequent production of superoxide <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b21">22]</ref>. The studies mentioned above indicated that NEI network has a tight connection with endothelial function.</p><p>Observing the profile of NEI network is a good method to distinguish disease states induced by different risk factors, this approach is similar to the Metabonomics <ref type="bibr" target="#b22">[23]</ref>, which used metabolic fingerprints to study the physiopathologic state. However, the potential biomarkers found by metabonomics may be surrogates of the metabolic process rather than direct reporters of disease target. Conversely, NEI network has tight connection with disease state, and the discriminating indices captured in the PCA loading plots may lead to therapeutic targets. For example, in this study, we found the levels of T4 in the three model groups were significantly lower than the control group, and these changes can be reserved by simvastatin. This result suggested that T4 may be the key index for vascular endothelial dysfunction. Clinical studies have shown that there is an association between subclinical hypothyroidism and coronary artery disease, and that after treatment with L-thyroxine the endothelial function in the subclinical hypothyroidism patients was improved <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b23">24]</ref>. This fact supported the idea that T4 plays a key role in endothelial function.</p><p>In addition, NEI network can also be used to evaluate drug effects. In this study, significant effects on the NEI network were observed in the simvastatin group. It is particularly suitable for the evaluation of Chinese medicine, which acts through complex mechanisms featured as multicompound, multitarget and multipathway. It has become more recognized that Chinese medicine produces the healing efficacy in a more holistic way. However, researchers typically only focus on a single or several indices associated with a disease. Obviously, NEI network is a better indicator for Chinese medicine to evaluate its holistic effect on the body.</p><p>In summary, the changes of NEI network were well observed in the three endothelial dysfunction model groups. The effect of simvastatin treatment in the NEI network was also studied. The results indicated that NEI network has a tight connection with endothelial function, and this rela-182 L Li, et al tionship can be used to distinguish different risk factors and evaluate drug effects. It should be noted that, the mechanisms of endothelial dysfunction are now well recognized, therefore, these aspects are not the focus of the study.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Neurotransmitters: 5 -</head><label>5</label><figDesc>Hydroxytryptamine (5-HT), dopamine (DA); Hypothalamus-hypophysis-adrenal cortex axis (HPAA): corticotropin releasing hormone (CRH), adrenocorticotropic hormone (ACTH), corticosterone (CORT); Hypothalamus-hypophysis-thyroid gland axis (HPTA): Thyrotropin releasing hormone (TRH), thyrotropic stimulating hormone (TSH), thyroid hormone (T3,T4); Sympathesis-adrenal-medulla axis (SAM): norepinephrine (NE), epinephrine (E); Renin-angiotensin-aldosterone system (RAAS): plasma renin activity (PRA), angiotensin II (AngII), aldosterone (ALD); Immune factors: Interleukin (IL)-1β, IL-2, IL-6, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 3 .</head><label>3</label><figDesc>The key indices selected from PCA model exemplified a clear distinction among the groups (Mean±SD). Significant difference between each model group (n=10) and the control group (n=10) is based on a two-tailed Dunnett's t-test (*p＜0.05, **p＜0.01), and significant difference between the Hcy+HFD group (n=10) and the simvastatin group (n=10) is based on a two-tailed student's t-test ( △ p＜0.05, △△ p ＜0.01).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc>Endothelial function indices (mean±SD, n=10 per group)</figDesc><table><row><cell>Fig. 1. Scatter plot of the ratio of</cell></row><row><cell>each NEI network index of the test</cell></row><row><cell>group relative to that of the related</cell></row><row><cell>control group. Error bars represent</cell></row><row><cell>the 95% confidence interval of the</cell></row><row><cell>ratio value. Squares, triangles and</cell></row><row><cell>circles in the figure indicate that the</cell></row></table><note>95% confidence interval of the ratio value is less than 1, covers 1 or is higher than 1, respectively. The 95% confidence interval of the ratio value was estimated by a 1000 times re- peated bootstrapping method.</note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p>This work was supported by the National Natural Science Funds Fund (81303279), grants from the National Basic Research Program of China (2012CB518600), the National Key Project for IND (2012ZX09303-003, 2012ZX09303009-001), and the Leading Academic Discipline Project of Shanghai Municipal Education Commission (085ZY1202, SYZ11056, ZYSNXD-CC-LCPJ).</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Network of immune-neuroendocrine interactions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Besedovsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Sorkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="1977" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The pathogenesis of atherosclerosis: a perspective for the 1990s</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Russell</forename><surname>Ross</surname></persName>
		</author>
		<idno type="DOI">10.1038/362801a0</idno>
		<idno type="PMID">8479518</idno>
		<idno type="ark">ark:/67375/GT4-4L6L5VDV-6</idno>
		<idno type="istexId">4BE7FC0886B915B592B15A56660B48F2888D2994</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<biblScope unit="issue">6423</biblScope>
			<biblScope unit="page" from="801" to="809" />
			<date type="published" when="1993-04" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Smoking and endothelial function</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rajesh</forename><surname>Puranik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">S</forename><surname>Celermajer</surname></persName>
		</author>
		<idno type="DOI">10.1053/pcad.2003.ypcad13</idno>
		<idno type="PMID">12800127</idno>
	</analytic>
	<monogr>
		<title level="j">Progress in Cardiovascular Diseases</title>
		<title level="j" type="abbrev">Progress in Cardiovascular Diseases</title>
		<idno type="ISSN">0033-0620</idno>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="443" to="458" />
			<date type="published" when="2003-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sameer</forename><surname>Ansar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juraj</forename><surname>Koska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">D</forename><surname>Reaven</surname></persName>
		</author>
		<idno type="DOI">10.1186/1475-2840-10-61</idno>
		<idno type="PMID">21736746</idno>
		<idno type="PMCID">PMC3184260</idno>
		<ptr type="open-access" target="https://cardiab.biomedcentral.com/track/pdf/10.1186/1475-2840-10-61" />
	</analytic>
	<monogr>
		<title level="j">Cardiovascular Diabetology</title>
		<title level="j" type="abbrev">Cardiovasc Diabetol</title>
		<idno type="ISSN">1475-2840</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">61</biblScope>
			<date type="published" when="2011" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Endothelial Dysfunction and the Risk of Hypertension: The Multi-Ethnic Study of Atherosclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Shimbo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Muntner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Viera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Homma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Polak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">G</forename><surname>Barr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Herrington</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Shea</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.109.143123</idno>
		<idno type="PMID">20308612</idno>
		<idno type="PMCID">PMC2896877</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.109.143123" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1210" to="1216" />
			<date type="published" when="2010-03-22" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><forename type="middle">M</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christiane</forename><surname>Hesse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christoph</forename><surname>Dehnert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heike</forename><surname>Siedler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Petra</forename><surname>Kleinbongard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hubert</forename><forename type="middle">J</forename><surname>Bardenheuer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Malte</forename><surname>Kelm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Bärtsch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Walter</forename><forename type="middle">E</forename><surname>Haefeli</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.200504-654oc</idno>
		<idno type="PMID">15947284</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/a89c/21a1f0d2a3a606ee942df3caa58dd0b35101.pdf" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<title level="j" type="abbrev">Am J Respir Crit Care Med</title>
		<idno type="ISSN">1073-449X</idno>
		<idno type="ISSNe">1535-4970</idno>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="763" to="767" />
			<date type="published" when="2005-09-15" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">K</forename><surname>Koh</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0008-6363(00)00146-2</idno>
		<idno type="PMID">10974215</idno>
		<ptr type="open-access" target="https://academic.oup.com/cardiovascres/article-pdf/47/4/648/755820/47-4-648.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cardiovascular Research</title>
		<idno type="ISSN">0008-6363</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="648" to="657" />
			<date type="published" when="2000-09" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">von Willebrand Factor Inhibition Improves Endothelial Function in Patients with Stable Angina</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olivier</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jozef</forename><surname>Bartunek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michalis</forename><surname>Hamilos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catalina</forename><forename type="middle">Trana</forename><surname>Berza</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fabio</forename><surname>Mangiacapra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Argyrios</forename><surname>Ntalianis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kristof</forename><surname>Vercruysse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christian</forename><surname>Duby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><surname>Wijns</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernard</forename><surname>De Bruyne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guy</forename><forename type="middle">R</forename><surname>Heyndrickx</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><surname>Vanderheyden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josefin-Beate</forename><surname>Holz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emanuele</forename><surname>Barbato</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12265-012-9422-3</idno>
		<idno type="PMID">23233321</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Cardiovascular Translational Research</title>
		<title level="j" type="abbrev">J. of Cardiovasc. Trans. Res.</title>
		<idno type="ISSN">1937-5387</idno>
		<idno type="ISSNe">1937-5395</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="364" to="370" />
			<date type="published" when="2012-12-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">High levels of soluble intercellular adhesion molecule-1, insulin resistance and saturated fatty acids are associated with endothelial dysfunction in healthy adolescents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Walter</forename><surname>Osika</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frida</forename><surname>Dangardt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Li-Ming</forename><surname>Gan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Birgitta</forename><surname>Strandvik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Friberg</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.atherosclerosis.2010.03.013</idno>
		<idno type="PMID">20362293</idno>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<title level="j" type="abbrev">Atherosclerosis</title>
		<idno type="ISSN">0021-9150</idno>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="638" to="642" />
			<date type="published" when="2010-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Ginsenoside Rg2 Inhibits Lipopolysaccharide-Induced Adhesion Molecule Expression in Human Umbilical Vein Endothelial Cell</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young-Suk</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chan</forename><forename type="middle">Hyung</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tae-Sun</forename><surname>Ha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sang</forename><forename type="middle">Jin</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hee</forename><forename type="middle">Yul</forename><surname>Ahn</surname></persName>
		</author>
		<idno type="DOI">10.4196/kjpp.2013.17.2.133</idno>
		<idno type="PMID">23626475</idno>
		<idno type="PMCID">PMC3634090</idno>
		<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0067KJPP/kjpp-17-133.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Korean Journal of Physiology &amp; Pharmacology</title>
		<title level="j" type="abbrev">Korean J Physiol Pharmacol</title>
		<idno type="ISSN">1226-4512</idno>
		<idno type="ISSNe">2093-3827</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">133</biblScope>
			<date type="published" when="2013" />
			<publisher>The Korean Physiological Society and The Korean Society of Pharmacology (KAMJE)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Hyperhomocysteinemia induced by folic acid deficiency and methionine load — applications of a modified HPLC method</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Durand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Fortin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Lussier-Cacan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Davignon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Blache</surname></persName>
		</author>
		<idno type="DOI">10.1016/0009-8981(96)06325-5</idno>
		<idno type="PMID">8814364</idno>
		<idno type="PII">0009-8981(96)06325-5</idno>
		<idno type="ark">ark:/67375/6H6-D9BQ12J4-L</idno>
		<idno type="istexId">F999D313677B5C80D6A0DA31D7833477EF097653</idno>
	</analytic>
	<monogr>
		<title level="j">Clinica Chimica Acta</title>
		<title level="j" type="abbrev">Clinica Chimica Acta</title>
		<idno type="ISSN">0009-8981</idno>
		<imprint>
			<biblScope unit="volume">252</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="83" to="93" />
			<date type="published" when="1996-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Simultaneous Determination of 3,4-Dihydroxyphenylalanine, 5-Hydroxytryptophan, Dopamine, 4-Hydroxy-3-Methoxyphenylalanine, Norepinephrine, 3,4-Dihydroxyphenylacetic Acid, Homovanillic Acid, Serotonin, and 5-Hydroxyindoleacetic Acid in Rat Cerebrospinal Fluid and Brain by High-Performance Liquid Chromatography with Electrochemical Detection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pierre</forename><surname>Vitali</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">G</forename><surname>Palfreyman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Monique</forename><surname>Zraika</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sylvie</forename><surname>Huot</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-4159.1982.tb07897.x</idno>
		<idno type="PMID">6174695</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Neurochemistry</title>
		<title level="j" type="abbrev">J Neurochem</title>
		<idno type="ISSN">0022-3042</idno>
		<idno type="ISSNe">1471-4159</idno>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1241" to="1254" />
			<date type="published" when="1982-05" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Principal component analysis of neuronal ensemble activity reveals multidimensional somatosensory representations</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">K</forename><surname>Chapin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miguel</forename><forename type="middle">A L</forename><surname>Nicolelis</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0165-0270(99)00130-2</idno>
		<idno type="PMID">10638820</idno>
		<idno type="PII">S0165-0270(99)00130-2</idno>
		<idno type="ark">ark:/67375/6H6-WGGQJRWH-W</idno>
		<idno type="istexId">1D950D24C5941C6E703BC794DAC4FC5BD2760E3A</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Neuroscience Methods</title>
		<title level="j" type="abbrev">Journal of Neuroscience Methods</title>
		<idno type="ISSN">0165-0270</idno>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="121" to="140" />
			<date type="published" when="1999-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Metabonomic Study on the Biochemical Profiles of A Hydrocortisone-Induced Animal Model</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Minjun</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Liping</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Jia</surname></persName>
		</author>
		<idno type="DOI">10.1021/pr050158o</idno>
		<idno type="PMID">16335992</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Proteome Research</title>
		<title level="j" type="abbrev">J. Proteome Res.</title>
		<idno type="ISSN">1535-3893</idno>
		<idno type="ISSNe">1535-3907</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2391" to="2396" />
			<date type="published" when="2005-12" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Foreword for Neuroimmunomodulation in Health and Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adriana</forename><surname>Del Rey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Jane</forename><surname>Welsh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markus</forename><forename type="middle">J</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hugo</forename><forename type="middle">O</forename><surname>Besedovsky</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1749-6632.2012.06678.x</idno>
		<idno type="PMID">22823446</idno>
		<idno type="ark">ark:/67375/WNG-Q43ZHXBR-0</idno>
		<idno type="istexId">490451B6E48C98258A1C927FDBAD18683F5D94D5</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of the New York Academy of Sciences</title>
		<idno type="ISSN">0077-8923</idno>
		<imprint>
			<biblScope unit="volume">1262</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="vii" to="viii" />
			<date type="published" when="2012-07" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Introduction: Immune-Neuroendocrine Network</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">O</forename><surname>Besedovsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Del Rey</surname></persName>
		</author>
		<idno type="DOI">10.1159/000061055</idno>
		<idno type="PMID">11789344</idno>
	</analytic>
	<monogr>
		<title level="m">Frontiers of Hormone Research</title>
		<imprint>
			<publisher>KARGER</publisher>
			<date type="published" when="2001" />
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1" to="14" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dov</forename><surname>Freimark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Micha</forename><forename type="middle">S</forename><surname>Feinberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shlomi</forename><surname>Matezky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naomi</forename><surname>Hochberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Shechter</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2004.04.013</idno>
		<idno type="PMID">15523321</idno>
	</analytic>
	<monogr>
		<title level="j">American Heart Journal</title>
		<title level="j" type="abbrev">American Heart Journal</title>
		<idno type="ISSN">0002-8703</idno>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="878" to="882" />
			<date type="published" when="2004-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Szabó</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Pacher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Zsengellér</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Vaslin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Komjáti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Benkö</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">G</forename><surname>Mabley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kollai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="28" to="35" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Effects of thyroxine replacement on endothelial function and carotid artery intima-media thickness in female patients with mild subclinical hypothyroidism</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Cabral</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Teixeira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Soares</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Leite</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Salles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Waisman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinics</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1321" to="1328" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Effects of corticotropin-releasing hormone (CRH) on endothelin-1 and NO release, mediated by CRH receptor subtype R2: A potential link between stress and endothelial dysfunction?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ute</forename><surname>Wilbert-Lampen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anja</forename><surname>Trapp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michaela</forename><surname>Modrzik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barbara</forename><surname>Fiedler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Florian</forename><surname>Straube</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrea</forename><surname>Plasse</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpsychores.2006.07.001</idno>
		<idno type="PMID">17011352</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychosomatic Research</title>
		<title level="j" type="abbrev">Journal of Psychosomatic Research</title>
		<idno type="ISSN">0022-3999</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="453" to="460" />
			<date type="published" when="2006-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Tumor Necrosis Factor- Induces Endothelial Dysfunction in the Prediabetic Metabolic Syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Picchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Belmadani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">J</forename><surname>Potter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Focardi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">M</forename><surname>Chilian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.res.0000229685.37402.80</idno>
		<idno type="PMID">16741160</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.RES.0000229685.37402.80" />
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<title level="j" type="abbrev">Circulation Research</title>
		<idno type="ISSN">0009-7330</idno>
		<idno type="ISSNe">1524-4571</idno>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="69" to="77" />
			<date type="published" when="2006-06-08" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Tat-Mediated p66shc Transduction Decreased Phosphorylation of Endothelial Nitric Oxide Synthase in Endothelial Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sang</forename><forename type="middle">Ki</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ji</forename><forename type="middle">Young</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hee</forename><forename type="middle">Kyoung</forename><surname>Joo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eun</forename><forename type="middle">Jung</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cuk</forename><forename type="middle">Seong</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sang</forename><forename type="middle">Do</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><forename type="middle">Bong</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Byeong</forename><forename type="middle">Hwa</forename><surname>Jeon</surname></persName>
		</author>
		<idno type="DOI">10.4196/kjpp.2012.16.3.199</idno>
		<idno type="PMID">22802702</idno>
		<idno type="PMCID">PMC3394923</idno>
		<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0067KJPP/kjpp-16-199.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Korean Journal of Physiology &amp; Pharmacology</title>
		<title level="j" type="abbrev">Korean J Physiol Pharmacol</title>
		<idno type="ISSN">1226-4512</idno>
		<idno type="ISSNe">2093-3827</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">199</biblScope>
			<date type="published" when="2012" />
			<publisher>The Korean Physiological Society and The Korean Society of Pharmacology (KAMJE)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The Metabolome-Wide Association Study: A New Look at Human Disease Risk Factors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeremy</forename><forename type="middle">K</forename><surname>Nicholson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elaine</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Elliott</surname></persName>
		</author>
		<idno type="DOI">10.1021/pr8005099</idno>
		<idno type="PMID">18707153</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Proteome Research</title>
		<title level="j" type="abbrev">J. Proteome Res.</title>
		<idno type="ISSN">1535-3893</idno>
		<idno type="ISSNe">1535-3907</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="3637" to="3638" />
			<date type="published" when="2008-09-05" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The Beneficial Effect ofl-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Salman</forename><surname>Razvi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lorna</forename><surname>Ingoe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gill</forename><surname>Keeka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Crispian</forename><surname>Oates</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carolyn</forename><surname>Mcmillan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jolanta</forename><forename type="middle">U</forename><surname>Weaver</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2006-1869</idno>
		<idno type="PMID">17299073</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/92/5/1715/9052713/jcem1715.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1715" to="1723" />
			<date type="published" when="2007-05" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
